AstraZeneca: Baxdrostat Phase 3 results posted, Saphnelo label updated, new China lupus trialAug 7Weekly roundup, 5 itemsanifrolumab-fniaAstraZeneca
Aurinia starts PRESERVE trial combining LUPKYNIS with biologics in lupus nephritisAug 6Quarterly updateAurinia Pharmaceuticals Inc.voclosporin
AstraZeneca posts NATRON Phase III benralizumab results; registers ROSY-S anifrolumab rollover studyJul 10Weekly roundup, 9 itemsanifrolumab-fniaAstraZeneca
Sign inSign in